MUC1 and non-small cell lung carcinoma: MUC1 is commonly overexpressed in NSCLC cells, and pre-clinical studies have implicated MUC1 in driving epithelial-to-mesenchymal transition (EMT), immune evasion, and chemotherapy resistance [134–138].